Cargando…
Adenosine-A2A Receptor Pathway in Cancer Immunotherapy
A2A receptors (A2AR), a typical GPCR with a high affinity for adenosine, was expressed in many immune cells, such as regulatory T cells, cytotoxic T cells, macrophages, etc. Adenosine binding to the A2AR receptor activates the typical G protein and triggers the cAMP/PKA/CREB pathway. The adenosine-A...
Autores principales: | Sun, Changfa, Wang, Bochu, Hao, Shilei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8977492/ https://www.ncbi.nlm.nih.gov/pubmed/35386701 http://dx.doi.org/10.3389/fimmu.2022.837230 |
Ejemplares similares
-
Editorial: Adenosine pathways in cancer immunity and immunotherapy
por: Fu, Junjiang, et al.
Publicado: (2023) -
Adenosine signaling: Optimal target for gastric cancer immunotherapy
por: Wang, Junqing, et al.
Publicado: (2022) -
Immunosuppressive adenosine-targeted biomaterials for emerging cancer immunotherapy
por: Wei, Qi, et al.
Publicado: (2022) -
Targeting Adenosine in Cancer Immunotherapy to Enhance T-Cell Function
por: Vigano, Selena, et al.
Publicado: (2019) -
Mast Cell Adenosine Receptors Function: A Focus on the A3 Adenosine Receptor and Inflammation
por: Rudich, Noam, et al.
Publicado: (2012)